Colleen M.

Colleen M. has extensive experience in regulatory affairs and quality assurance. Colleen currently holds the position of SVP, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics since January 2022. Prior to this, they were the VP, Global Regulatory Affairs and Quality Assurance at the same company from October 2021 to January 2022.

Before joining Avalo Therapeutics, Colleen M. worked as the VP, Regulatory Affairs at Cerecor Inc. from August 2020 to August 2021. Colleen also served as a Senior Regulatory Consultant at Takeda from September 2019 to August 2020.

Colleen M. held the role of Head, Regulatory Affairs at Aclaris Therapeutics, Inc. from August 2018 to September 2019. Colleen also worked as a Senior Consultant at Galera Therapeutics, Inc. from September 2017 to August 2018.

Earlier in their career, Colleen M. worked as a Regulatory Consultant at BioMarin Pharmaceutical Inc. from January 2013 to May 2016. Colleen also worked in the Regulatory Affairs department at ViroPharma Incorporated from January 2010 to 2012.

Colleen M. has experience in US Regulatory Affairs from October 2008 to 2010 at Endo Pharmaceuticals. Prior to that, they worked in the Regulatory Affairs departments at Cephalon from 2004 to June 2008 and at Wyeth from 2000 to 2004.

Colleen M. holds a Master of Science degree in Pharmaceutical Quality Assurance/Regulatory Affairs from Temple University. Prior to that, they earned a Bachelor of Science degree in Public Health from Richard Stockton College of New Jersey.